Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances

Blood

Volumn 97, Issue 6, 2001, Pages 1845-1853

  Franke, Sabine ^a   Wlodarska, Iwona ^a   Maes, Brigitte ^a   Vandenberghe, Peter ^a   Delabie, Jan ^a   Hagemeijer, Anne ^a   De Wolf Peeters, Chris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 1; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 22; CHROMOSOME 2Q; CHROMOSOME 3; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; HODGKIN DISEASE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REED STERNBERG CELL; X CHROMOSOME; Y CHROMOSOME;

EID: 0035869251     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.6.1845     Document Type: Article

References (68)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. Hodgkin's disease, lymphocyte predominance type, nodular - Further evidence for a B cell derivation: L & H variants of Reed-Sternberg cells express L26, a pan B cell marker
3. Hodgkin's disease with CD 20 (B1) positive Reed-Sternberg cells - An immunohistochemical and immunoelectron microscopic study
4. Nodular lymphocyte predominance Hodgkin's disease: A distinct clinicopathological entity
5. Molecular single cell studies of normal and transformed lymphocytes
6. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B
7. Clonality in nodular lymphocyte-predominant Hodgkin's disease
8. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells
9. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma
10. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell
11. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
12. Lymphocyte predominance Hodgkin's disease: Lineage and clonality determination using a single-cell assay
13. Classical Hodgkin and Reed-Sternberg cells demonstrate a nonclonal immature B lymphoid lineage: Evidence from a single cell assay and in situ hybridization
14. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells
15. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: Immunophenotypic and molecular studies
16. Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: Association with inflammatory bowel disease and immunosuppression
17. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease
18. Chromosome aberrations in adult Hodgkin disease in a Danish population-based study
19. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: A contribution to the characterization of tumor cells
20. The Reed-Sternberg cells of Hodgkin disease are clonal
21. Detection of numerical karyotype changes in the giant cells of Hodgkin's lymphomas by a combination of FISH and immunohistochemistry applied to paraffin sections
22. Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization
23. + Hodgkin cells
24. Clonal analysis of Hodgkin's disease shows absence of TCR/lg gene rearrangement, compared with T-cell-rich B-cell lymphoma and incipient adult T-cell leukemia/lymphoma
25. Single-cell analysis of the t(14;18)(q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells
26. Cytogenetic findings in nodular paragranuloma (Hodgkin's disease with lymphocytic predominance; nodular) and in progressively transformed germinal centers
27. Cytogenetic and immunologic phenotype findings in Hodgkin's disease
28. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines
29. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma
30. Cytogenetic and molecular genetic analysis of abnormal cells in Hodgkin's disease
31. Serial cytogenetic studies showing persistence of original clone in Hodgkin's disease
32. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization
33. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
34. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
35. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
36. Trisomy 3 in marginal zone B-cell lymphoma: A study based on cytogenetic analysis and fluorescence in situ hybridization
37. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease
38. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
39. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
40. DNA copy number losses in human neoplasms
41. Deletions involving two distinct regions of 6q in Bcell non-Hodgkin lymphoma
42. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization
43. Expression and rearrangement of the ROS1 gene in human glioblastoma cells
44. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
45. Chromosomal and gene amplification in diffuse large B-cell lymphoma
46. DNA copy number changes in diffuse large B-cell lymphoma - Comparative genomic hybridization study
47. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells
48. Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma
49. Chromosomal imbalances in primary lymphomas of the central nervous system
50. Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas
51. Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features
52. Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: Frequent occurrence of dicentric rearrangements and possible association with adverse outcome
53. Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy
54. Chromosome 17- and p53 changes in lymphoma
55. p53 expression in Reed-Sternberg cells of Hodgkin's disease
56. Allelic deletion on chromosome 17p13.3 in early ovarian cancer
57. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality
58. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations
59. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
60. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas
61. The t(2;3)(q21; q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5′ regulatory region and chromosomal breakpoints distant from the gene
62. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor
63. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma
64. Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma
65. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease
66. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease
67. Rearrangement of the bcl-6 gene in Hodgkin's disease, lymphocyte predominant type